Clinical Trial Update: Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating repeated neural stem cell based virotherapy for newly diagnosed high-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Snippet

Sponsor: Northwestern University | Conditions: Glioma, Malignant, New Diagnosis Tumor | Phase 1 | Status: RECRUITING